276 related articles for article (PubMed ID: 35412391)
1. Evaluation of Therapeutic Vancomycin Monitoring in Taiwan.
Chen TT; Liu MP; Sun HC
Microbiol Spectr; 2022 Apr; 10(2):e0156221. PubMed ID: 35412391
[TBL] [Abstract][Full Text] [Related]
2. Cost comparison of AUC:MIC- versus trough-based vancomycin monitoring for MRSA bacteremia.
Beccari MV; Seabury RW; Mogle BT; Kufel WD; Miller CD; Steele JM
J Am Pharm Assoc (2003); 2020; 60(5):729-733. PubMed ID: 32224054
[TBL] [Abstract][Full Text] [Related]
3. Optimal exposure targets for vancomycin in the treatment of neonatal coagulase-negative Staphylococcus infection: A retrospective study based on electronic medical records.
Chen Q; Wan J; Shen W; Lin W; Lin X; Huang Z; Lin M; Chen Y
Pediatr Neonatol; 2022 May; 63(3):247-254. PubMed ID: 35190273
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Vancomycin Area-Under-the-Curve Dosing Versus Trough Target-Based Dosing in Obese and Nonobese Patients With Methicillin-Resistant
Covvey JR; Erickson O; Fiumara D; Mazzei K; Moszczenski Z; Slipak K; Nemecek BD; Zimmerman DE; Guarascio AJ
Ann Pharmacother; 2020 Jul; 54(7):644-651. PubMed ID: 31888350
[No Abstract] [Full Text] [Related]
5. Implementation of vancomycin AUC/MIC dosing vs traditional trough dosing and incidence of acute kidney injury at a rural community hospital.
McClure S; McElroy L; Gugkaeva Z
Am J Health Syst Pharm; 2024 May; 81(11):e283-e288. PubMed ID: 38253056
[TBL] [Abstract][Full Text] [Related]
6. Are Vancomycin Trough Concentrations of 15 to 20 mg/L Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Infection?
Hale CM; Seabury RW; Steele JM; Darko W; Miller CD
J Pharm Pract; 2017 Jun; 30(3):329-335. PubMed ID: 27074786
[TBL] [Abstract][Full Text] [Related]
7. The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing.
Tsutsuura M; Moriyama H; Kojima N; Mizukami Y; Tashiro S; Osa S; Enoki Y; Taguchi K; Oda K; Fujii S; Takahashi Y; Hamada Y; Kimura T; Takesue Y; Matsumoto K
BMC Infect Dis; 2021 Feb; 21(1):153. PubMed ID: 33549035
[TBL] [Abstract][Full Text] [Related]
8. The Impact of AUC-Based Monitoring on Pharmacist-Directed Vancomycin Dose Adjustments in Complicated Methicillin-Resistant
Stoessel AM; Hale CM; Seabury RW; Miller CD; Steele JM
J Pharm Pract; 2019 Aug; 32(4):442-446. PubMed ID: 29554847
[TBL] [Abstract][Full Text] [Related]
9. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
Rybak MJ; Le J; Lodise TP; Levine DP; Bradley JS; Liu C; Mueller BA; Pai MP; Wong-Beringer A; Rotschafer JC; Rodvold KA; Maples HD; Lomaestro BM
Pharmacotherapy; 2020 Apr; 40(4):363-367. PubMed ID: 32227354
[TBL] [Abstract][Full Text] [Related]
10. The Safety and Efficacy of AUC/MIC-Guided vs Trough-Guided Vancomycin Monitoring Among Veterans.
Folkers A; Anderson R; Harris J; Rogen C
Fed Pract; 2023 Jan; 40(1):28-33. PubMed ID: 37223240
[TBL] [Abstract][Full Text] [Related]
11. Association between single trough-based area under the curve estimation of vancomycin and treatment outcome among methicillin-resistant Staphylococcus aureus bacteremia patients.
Makmor-Bakry M; Ahmat A; Shamsuddin A; Lau CL; Ramli R
Anaesthesiol Intensive Ther; 2019; 51(3):218-223. PubMed ID: 31434472
[TBL] [Abstract][Full Text] [Related]
12. Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC?
Patel K; Crumby AS; Maples HD
Paediatr Drugs; 2015 Apr; 17(2):97-103. PubMed ID: 25644329
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.
Prybylski JP
Pharmacotherapy; 2015 Oct; 35(10):889-98. PubMed ID: 26497475
[TBL] [Abstract][Full Text] [Related]
14. Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.
Yoo R; So H; Seo E; Kim M; Lee J
PLoS One; 2021; 16(4):e0247714. PubMed ID: 33793589
[TBL] [Abstract][Full Text] [Related]
15. Clinical validation of the two-point method for predicting vancomycin AUC based on peak and trough plasma concentrations.
Wang L; Lin X; Wang L; Ye H; Lin Y; Ruan J; Shi S
Int J Clin Pharm; 2022 Dec; 44(6):1325-1331. PubMed ID: 36136207
[TBL] [Abstract][Full Text] [Related]
16. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
Rybak MJ; Le J; Lodise TP; Levine DP; Bradley JS; Liu C; Mueller BA; Pai MP; Wong-Beringer A; Rotschafer JC; Rodvold KA; Maples HD; Lomaestro B
Clin Infect Dis; 2020 Sep; 71(6):1361-1364. PubMed ID: 32658968
[TBL] [Abstract][Full Text] [Related]
18. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
Gawronski KM; Goff DA; Brown J; Khadem TM; Bauer KA
Clin Ther; 2013 Jun; 35(6):772-9. PubMed ID: 23795575
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin Area Under the Curve-Guided Dosing and Monitoring for Adult and Pediatric Patients With Suspected or Documented Serious Methicillin-Resistant Staphylococcus aureus Infections: Putting the Safety of Our Patients First.
Lodise TP; Drusano G
Clin Infect Dis; 2021 May; 72(9):1497-1501. PubMed ID: 33740042
[TBL] [Abstract][Full Text] [Related]
20. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
